Succinate dehydrogenase B-deficient cancer cells are highly sensitive to bromodomain and extra-terminal inhibitors-Reference-Cited by-同舟云学术

Succinate dehydrogenase B-deficient cancer cells are highly sensitive to bromodomain and extra-terminal inhibitors

Published:2017-03-07 Issue:17 Volume:8 Page:28922-28938
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kitazawa Satoshi¹,Ebara Shunsuke¹,Ando Ayumi²,Baba Yuji¹,Satomi Yoshinori²,Soga Tomoyoshi³,Hara Takahito¹

Affiliation:

1. Oncology Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, 251-8555, Japan

2. Integrated Technology Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, 251-8555, Japan

3. Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, 997-0052, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in CRISPR-Cas systems for colorectal cancer research and therapeutics;Expert Review of Molecular Diagnostics;2024-08-02

2. The mitochondrial protease ClpP is a druggable target that controls VSMC phenotype by a SIRT1-dependent mechanism;Redox Biology;2024-07

3. Mitochondrial metabolism as a dynamic regulatory hub to malignant transformation and anti-cancer drug resistance;Biochemical and Biophysical Research Communications;2024-01

4. Metabolic adaptation of NK cell activity and behavior in tumors: challenges and therapeutic opportunities;Trends in Pharmacological Sciences;2023-11

5. Succinate metabolism: a promising therapeutic target for inflammation, ischemia/reperfusion injury and cancer;Frontiers in Cell and Developmental Biology;2023-09-22